Bai-Shen Pan
Overview
Explore the profile of Bai-Shen Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
616
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huo R, Yang W, Liu Y, Liu T, Li T, Wang C, et al.
Phytomedicine
. 2024 Apr;
129:155225.
PMID: 38678948
Background: Hepatocellular carcinoma (HCC), the most primary malignant liver tumor and is ranked as the fifth most common malignancy worldwide. Despite various therapeutic approaches being used in clinical practice, the...
2.
Dai Q, Zhu J, Yang J, Zhang C, Yang W, Pan B, et al.
Curr Stem Cell Res Ther
. 2024 Apr;
20(1):103-122.
PMID: 38561604
Background: Cancer stem cells (CSC) play an important role in the development of Liver Hepatocellular Carcinoma (LIHC). However, the regulatory mechanisms between acetylation- associated genes (HAGs) and liver cancer stem...
3.
Jin A, Ding L, Yang W, Liu T, Chen W, Li T, et al.
BMC Gastroenterol
. 2022 Dec;
22(1):505.
PMID: 36482325
Background: Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and third leading cause of cancer-related death worldwide in 2020. Exosomes derived from cancer-associated fibroblasts (CAFs-exo) can promote tumor...
4.
Jin A, Zhang C, Zheng W, Xian J, Yang W, Liu T, et al.
Clin Transl Med
. 2022 Apr;
12(4):e794.
PMID: 35384345
Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. As a cell adhesion molecule, poliovirus receptor (PVR/CD155) is abnormally overexpressed in tumour cells, and related to tumour proliferation...
5.
Ding L, Yu Q, Yang S, Yang W, Liu T, Xian J, et al.
Front Immunol
. 2022 Apr;
13:831101.
PMID: 35371079
Background: Inhibitory immune checkpoint proteins promote tumor immune escape and are associated with inferior patient outcome. However, the biological functions and regulatory roles of one of its members, HHLA2, in...
6.
Jin A, Yang Y, Su X, Yang W, Liu T, Chen W, et al.
J Clin Lab Anal
. 2022 Jan;
36(3):e24259.
PMID: 35089611
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies with poor prognosis. There is no research about the clinical significance of serum soluble CD155 (sCD155) level for HCC....
7.
Yang W, Sun Y, Jin A, Lv L, Zhu J, Wang B, et al.
Cell Death Dis
. 2020 Oct;
11(10):895.
PMID: 33093445
Accumulating evidence indicates that hepatocellular carcinoma (HCC) tumorigenesis, recurrence, metastasis, and therapeutic resistance are strongly associated with liver cancer stem cells (CSCs), a rare subpopulation of highly tumorigenic cells with...
8.
Ma X, Qu X, Yang W, Wang B, Shen M, Zhou Y, et al.
Clin Chim Acta
. 2020 Sep;
511:67-74.
PMID: 32979338
Aims: The present study aimed to determine the prognostic significance of soluble Programmed Death-ligand 1 (sPD-L1) in hepatocellular carcinoma (HCC) patients undergoing transcatheter arterial chemoembolization (TACE). Methods: We treated 114...
9.
Ma X, Sun Y, Wang B, Shen M, Zhou Y, Chen J, et al.
BMC Cancer
. 2019 Aug;
19(1):760.
PMID: 31370822
Backgrounds: The role of sphere-forming culture in enriching subpopulations with stem-cell properties in hepatocellular carcinoma (HCC) is unclear. The present study investigates its value in enriching cancer stem cells (CSCs)...
10.
Ma X, Shen M, Hu B, Wang B, Yang W, Lv L, et al.
J Hematol Oncol
. 2019 Apr;
12(1):37.
PMID: 30971294
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide because of rapid progression and high incidence of metastasis or recurrence. Accumulating evidence shows that CD73-expressing tumor cell...